Healthcare
Option Care Health, Inc.(OPCH)
Live Price
Offline$20.08
-2.10% today
1Y Change
-33.00%
Window
Jun 25, 2025 โ Jun 22, 2026
- Market Cap
- $3.13B
- Revenue Growth
- +13.0%
- EPS Growth
- +4.1%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 25, 2025 โ Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Option Care Health, Inc. (OPCH) is a Healthcare stock with a market cap of $3.13B and listed on NASDAQ. The stock last traded around $20.08 and down 33.0% across the available one-year price window (Jun 25, 2025 โ Jun 22, 2026). Baseline metrics include revenue growth of +13.0%, EPS growth of +4.1%, a dividend yield of 0.0%. What stands out right now is revenue +13.0%, EPS +4.1%, free cash flow -10.2% with operating margin 5.9% and ROIC 9.3%. Valuation is more restrained than many high-expectation growth names at P/E 15.2 and price/sales 0.6. Stock Foundry combines OPCH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+13.0% vs +7.6% peer median
Operating Margin
Below sector median
+5.9% vs +19.4% peer median
P/E
Below sector median
15.2 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 29, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +13.0% and EPS at +4.1%, with operating margin around 5.9%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -9.5% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 29, 2026 | โ | -24.3% | -23.9% | -19.7% |
2026 Feb 24, 2026 | +0.0% | -0.7% | -7.7% | -16.0% |
2025 Oct 30, 2025 | +4.7% | -0.7% | +3.2% | +18.7% |
Benchmark Edge
OPCH vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
OPCH
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
OPCH Max Drawdown
-46.65%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for OPCH and SPY.
Company Overview
Option Care Health, Inc.
NASDAQ Global Select
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
- Leadership
- Luke Whitworth
- IPO Date
- Aug 15, 1996
- Employees
- 8.0k
- Street Address
- 3000 Lakeside Drive
- Mailing
- Bannockburn, IL, 60015
- Region
- Bannockburn, IL, US
- Reporting Currency
- USD
- Investor Line
- 312 940 2443
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 15.2
- EV/EBITDA
- 7.3
- Price/Sales
- 0.6
- Price/Book
- 2.3
Growth
- Revenue
- +13.0%
- EPS
- +4.1%
- Free Cash Flow
- -10.2%
Profitability
- Gross Margin
- 18.0%
- Operating Margin
- 5.9%
- Net Margin
- 3.6%
- ROE
- 15.3%
- ROIC
- 9.3%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 1.64
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.